PegBio Raises HK$ 80.04 Million in Share Placement

• PegBio completed a placement of 26,813,000 new H shares on November 10, 2026.
• The placement price was HKD 2.985 per share, raising approximately HKD 80.04 million in gross proceeds.
• Net proceeds totaled approximately HKD 77.16 million; the new shares represented 6.42% of enlarged share capital.
• Pipeline R&D will receive 60% of net proceeds; loan repayment and capital strengthening will receive 20%.
• The remaining 20% will fund general corporate purposes and working capital; all proceeds are expected to be utilized by December 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261110-12406952), on November 10, 2026, and is solely responsible for the information contained therein.